Exact Mass: 408.0823

Exact Mass Matches: 408.0823

Found 43 metabolites which its exact mass value is equals to given mass value 408.0823, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetracenomycin E

Tetracenomycin E

C22H16O8 (408.0845)


   

Tetracenomycin B2

8-Demethyltetracenomycin A2

C22H16O8 (408.0845)


   

Ethyl biscoumacetate

Ethyl 2,2-bis(4-hydroxy-2-oxo-2H-chromen-3-yl)acetic acid

C22H16O8 (408.0845)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

Susalimod

2-Hydroxy-5-(2-{4-[(3-methylpyridin-2-yl)sulphamoyl]phenyl}ethynyl)benzoic acid

C21H16N2O5S (408.078)


   

3,5,7,4-Tetrahydroxy-3-(5-formyl-2-hydroxyphenyl)flavanone

3,5,7,4-Tetrahydroxy-3- (5"-formyl-2"-hydroxyphenyl) flavanone

C22H16O8 (408.0845)


   

Anhydromaggiemycin

Anhydromaggiemycin

C22H16O8 (408.0845)


   

Prostalidin B

Prostalidin B

C22H16O8 (408.0845)


   

Torosaflavone C

(5bR,8aS)-rel-4H,5b,8a-Dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-6-methyl-8H-cyclopenta[4,5]furo[3,2-g]-1-benzopyran-4,8-dione

C22H16O8 (408.0845)


   

8-p-Hydroxybenzylquercetin

3,5,7,3,4-Pentahydroxy-8- (p-hydroxybenzyl) flavone

C22H16O8 (408.0845)


   

3,5,7-Trihydroxy-2,3-dihydro-2-(2,2-dihydroxy-5-formyl[1,1-biphenyl]-5-yl)-4H-1-benzopyran-4-one

3,5,7-Trihydroxy-2,3-dihydro-2-(2,2-dihydroxy-5-formyl[1,1-biphenyl]-5-yl)-4H-1-benzopyran-4-one

C22H16O8 (408.0845)


   

n-Isorhodomycinone

n-Isorhodomycinone

C22H16O8 (408.0845)


   

CHEMBL3314372

CHEMBL3314372

C22H16O8 (408.0845)


   

Antibiotic Zgg

Antibiotic Zgg

C22H16O8 (408.0845)


   

9-[(2,3-Dihydro-6-hydroxy-2-(hydroxymethyl)-3-benzofuranyl)oxy]3,10-dihydroxy-6H-dibenzo[b,d]pyran-6-one

9-[(2,3-Dihydro-6-hydroxy-2-(hydroxymethyl)-3-benzofuranyl)oxy]3,10-dihydroxy-6H-dibenzo[b,d]pyran-6-one

C22H16O8 (408.0845)


   

C22H16O8

C22H16O8 (408.0845)


   

pericosine E

pericosine E

C16H21ClO10 (408.0823)


   

SCHEMBL17866783

SCHEMBL17866783

C22H16O8 (408.0845)


   

Ser-Phe4Cl-OH

(S)-3-(4-chlorophenyl)-2-(3-(2-hydroxyethoxy)-4-nitrobenzamido)propanoic acid

C18H17ClN2O7 (408.0724)


   

Phe4Cl-Thr-OH

(2S,3R)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)-3-hydroxybutanoic acid

C18H17ClN2O7 (408.0724)


   

1,2-Ethanediaminium,N1,N2-dimethyl-N1,N1,N2,N2-tetra-2-propen-1-yl-, bromide (1:2)

1,2-Ethanediaminium,N1,N2-dimethyl-N1,N1,N2,N2-tetra-2-propen-1-yl-, bromide (1:2)

C16H30Br2N2 (408.0776)


   

4-[4,5-DIHYDRO-5-(1H-INDOL-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-BENZENESULFONAMIDE

4-[4,5-DIHYDRO-5-(1H-INDOL-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-BENZENESULFONAMIDE

C18H15F3N4O2S (408.0868)


   

flavanthrone

flavanthrone

C28H12N2O2 (408.0899)


   

1,4-Bis(7-chloroquinolin-4-yl)piperazine

1,4-Bis(7-chloroquinolin-4-yl)piperazine

C22H18Cl2N4 (408.0908)


   

3,9-dibenzyl-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide

3,9-dibenzyl-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide

C19H22O6P2 (408.0892)


   

N10-(Trifluoroacetyl)pteroic acid

N10-(Trifluoroacetyl)pteroic acid

C16H11F3N6O4 (408.0794)


   

Pyrylium, 2,4,6-triphenyl-, perchlorate

Pyrylium, 2,4,6-triphenyl-, perchlorate

C23H17ClO5 (408.0764)


   

Disperse Yellow 114

Disperse Yellow 114

C20H16N4O4S (408.0892)


   

Leriglitazone hydrochloride

Leriglitazone hydrochloride

C19H21ClN2O4S (408.091)


C78272 - Agent Affecting Nervous System Leriglitazone (MIN-102; Hydroxypioglitazone) hydrochloride, a metabolite of pioglitazone. Leriglitazone hydrochloride PioOH is a PPARγ agonist, stabilizes the PPARγ activation function-2 (AF-2) co-activator binding surface and enhances co-activator binding, affording slightly better transcriptional efficacy. Leriglitazone hydrochloride binds to the PPARγ C-terminal ligand-binding domain (LBD) with a Ki of 1.2 μM，Leriglitazone induces transcriptional efficacy of the PPARγ (LBD) with an EC50 of 680 nM[1].

   

Susalimod

Susalimod

C21H16N2O5S (408.078)


C308 - Immunotherapeutic Agent

   

Ethyl Biscoumacetate

Ethyl Biscoumacetate

C22H16O8 (408.0845)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

(4s,8s,10s)-16-acetyl-2,12-dihydroxy-10-methyl-5,9-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1,3(11),12,15(20),16,18-hexaene-6,14,21-trione

(4s,8s,10s)-16-acetyl-2,12-dihydroxy-10-methyl-5,9-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1,3(11),12,15(20),16,18-hexaene-6,14,21-trione

C22H16O8 (408.0845)


   

methyl (3s,4s,5s,6s)-6-chloro-3,4-dihydroxy-5-{[(1s,4r,5r,6r)-4,5,6-trihydroxy-2-(methoxycarbonyl)cyclohex-2-en-1-yl]oxy}cyclohex-1-ene-1-carboxylate

methyl (3s,4s,5s,6s)-6-chloro-3,4-dihydroxy-5-{[(1s,4r,5r,6r)-4,5,6-trihydroxy-2-(methoxycarbonyl)cyclohex-2-en-1-yl]oxy}cyclohex-1-ene-1-carboxylate

C16H21ClO10 (408.0823)


   

methyl 2-ethyl-6,7,10,11-tetrahydroxy-5,12-dioxotetracene-1-carboxylate

methyl 2-ethyl-6,7,10,11-tetrahydroxy-5,12-dioxotetracene-1-carboxylate

C22H16O8 (408.0845)


   

2-[1,2-dihydroxy-1-(oxiran-2-yl)ethyl]-11-hydroxy-5-methyl-1-oxatetraphene-4,7,12-trione

2-[1,2-dihydroxy-1-(oxiran-2-yl)ethyl]-11-hydroxy-5-methyl-1-oxatetraphene-4,7,12-trione

C22H16O8 (408.0845)


   

methyl 2-ethyl-4,5,7,12-tetrahydroxy-6,11-dioxotetracene-1-carboxylate

methyl 2-ethyl-4,5,7,12-tetrahydroxy-6,11-dioxotetracene-1-carboxylate

C22H16O8 (408.0845)


   

16-acetyl-2,12-dihydroxy-10-methyl-5,9-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1,3(11),12,15(20),16,18-hexaene-6,14,21-trione

16-acetyl-2,12-dihydroxy-10-methyl-5,9-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1,3(11),12,15(20),16,18-hexaene-6,14,21-trione

C22H16O8 (408.0845)


   

[(2r,3r,4s,5r,8e)-9-(3,4-dihydroxyphenyl)-1,2,3,5-tetrahydroxy-6-oxonon-8-en-4-yl]oxysulfonic acid

[(2r,3r,4s,5r,8e)-9-(3,4-dihydroxyphenyl)-1,2,3,5-tetrahydroxy-6-oxonon-8-en-4-yl]oxysulfonic acid

C15H20O11S (408.0726)


   

2',6-dihydroxy-5'-[(2s,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carbaldehyde

2',6-dihydroxy-5'-[(2s,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carbaldehyde

C22H16O8 (408.0845)


   

methyl (3s,4r,5s,6s)-6-chloro-3,4-dihydroxy-5-{[(1s,4s,5r,6s)-4,5,6-trihydroxy-2-(methoxycarbonyl)cyclohex-2-en-1-yl]oxy}cyclohex-1-ene-1-carboxylate

methyl (3s,4r,5s,6s)-6-chloro-3,4-dihydroxy-5-{[(1s,4s,5r,6s)-4,5,6-trihydroxy-2-(methoxycarbonyl)cyclohex-2-en-1-yl]oxy}cyclohex-1-ene-1-carboxylate

C16H21ClO10 (408.0823)


   

methyl 6-chloro-3,4-dihydroxy-5-{[4,5,6-trihydroxy-2-(methoxycarbonyl)cyclohex-2-en-1-yl]oxy}cyclohex-1-ene-1-carboxylate

methyl 6-chloro-3,4-dihydroxy-5-{[4,5,6-trihydroxy-2-(methoxycarbonyl)cyclohex-2-en-1-yl]oxy}cyclohex-1-ene-1-carboxylate

C16H21ClO10 (408.0823)


   

2-{2,4-dihydroxy-6-[(4-hydroxy-6-oxopyran-2-yl)methyl]phenyl}-7-hydroxy-5-methylchromen-4-one

2-{2,4-dihydroxy-6-[(4-hydroxy-6-oxopyran-2-yl)methyl]phenyl}-7-hydroxy-5-methylchromen-4-one

C22H16O8 (408.0845)


   

2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carbaldehyde

2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carbaldehyde

C22H16O8 (408.0845)


   

[(2r,3r,4s,5r,8e)-9-(3,4-dihydroxyphenyl)-2,3,4,5-tetrahydroxy-6-oxonon-8-en-1-yl]oxysulfonic acid

[(2r,3r,4s,5r,8e)-9-(3,4-dihydroxyphenyl)-2,3,4,5-tetrahydroxy-6-oxonon-8-en-1-yl]oxysulfonic acid

C15H20O11S (408.0726)